<DOC>
	<DOCNO>NCT02809079</DOCNO>
	<brief_summary>Neuromyelitis optica ( NMO ) autoimmune inflammatory demyelinate disease central nervous system lead blindness paralysis . Since disability accrues incrementally related attack , attack prevention immunosuppressive therapy mainstay prevent disability . However , standard immunosuppressive treatment strategy NMO relapse prevention . In previous study , investigator provide evidence support use azathioprine plus low dose corticosteroid effective strategy associate reduction risk relapse Chinese patient NMO , azathioprine bone marrow suppression side effect . Mycophenolate mofetil ( MMF ) new immunosuppressant rapid onset , few side effect advantage . In recent year , MMF use different immune-related neurological disease ; literature show possible efficacy MMF NMO treatment . In research , multi-center ( Third Affiliated Hospital Sun Yat-sen University , Zhongshan Ophthalmic Centre Sun Yat-sen University , Nangfang Hospital Southern Medical University ) study carry evaluate efficacy safety mycophenolate mofetil therapy NMO spectrum disorder .</brief_summary>
	<brief_title>Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders Chinese Patients</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Neuromyelitis Optica</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Meet 2006 Wingerchuk diagnostic criterion ; NMOimmunoglobulin G seropositive ; Between 18 65 year old ; Relapse : 2 relapse recent 2 year ; 1 relapse recent 1 year ; Expanded disability status scale : expand disability status scale≤7.0 , visual acuity ≥20 / 100 least one eye Understand purpose procedure study , write informed consent obtain . Using immunosuppressive agent drug affect evaluation , drug withdrawal le 3 month ; Patients follow disease : transaminase elevation exceed 2 time normal upper limit ; white blood cell &lt; 4 × 109 / L , Hemoglobin &lt; 80g / L , platelet &lt; 100 × 109 / L ; With serious cardiovascular , liver , kidney vital organ blood , endocrine system diseases , cancer history ; With immunodeficiency , uncontrolled infection active gastrointestinal disease ( gastric ulcer , etc . ) ; Pregnancy , breastfeed woman male female plan conceive recently ; Allergy mycophenolate mofetil prednisone .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>